drugset / Trial / NCT00006230

Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer

NCT00006230 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of nitrocamptothecin in treating patients who have advanced ovarian cancer.

Timeline

Start
2000-05
Primary completion
2003-04
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject rubitecan Unknown — Oral

Indications